PRENW — Prenetics Global Limited

Summary of Prenetics Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Total Revenue: $36 million, up 334% year-over-year (from $8.3 million in Q1 2025).
• IM8 Contribution: $33.8 million, nearly 6x year-over-year growth and a 23% sequential increase from Q4 2025.
• Gross Profit: $23.3 million, a 315% increase year-over-year.
• Gross Margin: 64.8%, with IM8 gross margin at 64.3%, up from 16.3% in Q4 2025.
• Active Subscribers: 82,000, with 93% of IM8 revenue derived from subscriptions.
• Servings Delivered: 8.8 million, a 28% sequential increase.
• Adjusted EBITDA Loss: $5.6 million, compared to $4.5 million in Q1 2025.

2. Strategic Updates and Business Highlights

• Business Transformation: Prenetics has transitioned from a diagnostics and genome testing company to a consumer health company focused on recurring subscription revenue through IM8.
• Product Market Fit: The company reported strong traction with IM8, shipping to 43 countries and achieving significant daily servings.
• International Rollout: Successful completion of international quarterly subscription rollout, leading to increased average order values (AOV) from $110 to $240.
• Partnerships: Notable partnerships with athletes and teams, including David Beckham and Inter Miami CF, enhancing brand credibility without significant financial burden.
• Research Initiatives: Ongoing randomized controlled trials for gut health and longevity, aiming to strengthen product credibility.

3. Forward Guidance and Outlook

• 2026 Revenue Guidance: Raised to $190 million-$210 million for IM8, up from $180 million-$200 million.
• Q2 Revenue Expectations: Projected total revenue of $46 million-$48 million, with IM8 contributing $44 million-$46 million, indicating a 33% sequential growth.
• New Product Launches: Three new products (hydration, creatine, kids gummies) planned for Q4 2026, which are not included in current guidance and represent potential upside.

4. Bad News, Challenges, or Points of Concern

• Operating Loss: Continued operational losses of $8.9 million, which may raise concerns about profitability in the near term.
• Customer Orders Decline: A 4% decline in total customer orders quarter-over-quarter, attributed to a shift towards quarterly subscriptions rather than a decrease in demand.
• Marketing Spend: High marketing expenditure of $22 million in Q1, which may raise questions about the sustainability of customer acquisition costs.

5. Notable Q&A Insights

• Customer Acquisition Efficiency: The company is diversifying marketing channels beyond Meta (currently 85% of spend) to include TikTok and YouTube, with early testing showing promise.
• Retention Metrics: Retention rates for quarterly subscribers are higher than monthly subscribers, indicating strong customer loyalty.
• Market Expansion: Potential future growth in markets like China and India was discussed, highlighting long-term strategic opportunities.
• Cohort Performance: Current cohorts are generating revenue significantly faster than previous cohorts, indicating improved customer lifetime value metrics.

Overall, Prenetics showcased strong growth metrics and strategic initiatives in Q1 2026, while also addressing challenges related to operational losses and customer order dynamics. The outlook remains positive with raised revenue guidance and new product launches on the horizon.